Had a bad feeling going in for the biologic interview, what a "sh*t show".... HR was a joke and the managers looked frazzled....couldn't wait to get out of there. Honestly could not see myself trying to beg for scripts using their OLD data that is pathetic for PASI scores and compares to Enbrel, the oldest biologic on the market. Good luck to the reps who believed their song and dance....your launch will fail....
That is because the IL-23 comparative data that is already being shown at derm meetings shows Tildra on the weak end of the IL-23 class. Also, more side effects. Many think it is because the dosing is not right. Higher Tildra dose or shorter interval between doses will probably equal the IL-23 class. May increase the side effects? Keep in mind that IL-23 class is not showing any improvement over IL-17 and earlier classes. When you have 5-10 year data on safety with PASI 100s, it is hard to beat. Will be interesting.
Doesn't matter, Sun Pharma is a shit show, derms do not respect the company and reps will be BEGGING for scripts...
You can beg for topical steroid scripts. Maybe beg for Absorica scripts. Hard pressed to beg and win for expensive biological scripts that have AEs like lymphoma and systemic infection in the labeling. Also, most of the high volume prescribers are already on the take with bigger entities and deeper pockets. SUN cannot outbeg J&J, Abbvie, Pfizer, Lilly, and more. Line is long and the story is old and weak.
Those fools only chasing the money carrot Sun is putting in front of you, get used to chasing....scripts....derms HATE Sun Pharma and Abbvie's new IL23 will blow Sun away. No derm is going to write Tildra with your pathetic PASI scores and ancient data....
My friend, we are surely worried Abbvie will knock our sandals off. We are burning our incense to bring them bad luck.
Everyone from India is a doctor or technology person. Believe you automatically get a PhD when you come to the US, steal a US job, and get a six figure salary. To run an India based pharma company you do not need a degree. Just need f-bombs, a cattle whip, and a horn.
Offers are decent, but when you factor in the risk associated with the overall company, and that the drug is not yet approved, it's a bit of a sketchy move. I'm going to pass.
Sun paying overpriced reps to sit around and wait for Tildra to be approved, enjoy your 3-6 million nth tenure before it falls apart!
